Ravindra Kumar, SVP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 3,389 shares at $45.24 ($153K) on 2019-09-10, disclosed to the SEC on 2019-09-10.
Scheduled sale ($153k) by SVP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| XLRN | SELL | 2018-04-04 | $46K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |
| XLRN | SELL | 2017-09-14 | $196K | — | Filing → |